Targeting PFKFB3 as a potential strategy in infantile hemangioma treatment
Feb. 14, 2023
Infantile hemangioma (IH) is the most common benign vascular tumor seen in childhood. After an early proliferative phase in the first weeks of life, the majority of hemangiomas complete their growth and start to involute by approximately 12 months.